Work

P2.04-007 KEYNOTE-604: Phase 3 Randomized, Double-Blind Trial of Pembrolizumab/Placebo plus Etoposide/Platinum for Extensive Stage-SCLC

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.11.020

Authors: C. Rudin, L. Shen, M.C. Pietanza

Institutions: Memorial Sloan Kettering Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2769844907

FWCI: 0.757

Cites:

Cited by: 8

Related to: 10